Kezar Life Sciences Balance Sheet Health
Financial Health criteria checks 5/6
Kezar Life Sciences has a total shareholder equity of $134.0M and total debt of $10.3M, which brings its debt-to-equity ratio to 7.7%. Its total assets and total liabilities are $164.1M and $30.0M respectively.
Key information
7.7%
Debt to equity ratio
US$10.26m
Debt
| Interest coverage ratio | n/a |
| Cash | US$148.39m |
| Equity | US$134.05m |
| Total liabilities | US$30.04m |
| Total assets | US$164.09m |
Recent financial health updates
Is Kezar Life Sciences (NASDAQ:KZR) Using Debt Sensibly?
Dec 08
Is Kezar Life Sciences (NASDAQ:KZR) Using Too Much Debt?
Aug 15Recent updates
Is Kezar Life Sciences (NASDAQ:KZR) Using Debt Sensibly?
Dec 08FDA clears Kezar Life Sciences' drug application for autoimmune hepatitis treatment
Oct 03Is Kezar Life Sciences (NASDAQ:KZR) Using Too Much Debt?
Aug 15Kezar Life Sciences GAAP EPS of -$0.25 beats by $0.02
Aug 11Kezar Life Sciences: Regulatory Tailwinds Reverse Downside Case
Jul 27Kezar Life Sciences appoints Nick Mordwinkin as chief business officer
Jul 11We're Not Very Worried About Kezar Life Sciences' (NASDAQ:KZR) Cash Burn Rate
Jan 03Here's Why We're Not Too Worried About Kezar Life Sciences' (NASDAQ:KZR) Cash Burn Situation
Aug 26We're Not Very Worried About Kezar Life Sciences' (NASDAQ:KZR) Cash Burn Rate
Apr 05Here's What Kezar Life Sciences, Inc.'s (NASDAQ:KZR) Shareholder Ownership Structure Looks Like
Mar 01Kezar Life Sciences, Inc. (NASDAQ:KZR) Insiders Increased Their Holdings
Jan 25Kezar Life Sciences (NASDAQ:KZR) Is In A Good Position To Deliver On Growth Plans
Dec 21
Kezar Life Sciences selected for the Nasdaq Biotechnology Index
Dec 14Financial Position Analysis
Short Term Liabilities: KZR's short term assets ($156.4M) exceed its short term liabilities ($20.4M).
Long Term Liabilities: KZR's short term assets ($156.4M) exceed its long term liabilities ($9.6M).
Debt to Equity History and Analysis
Debt Level: KZR has more cash than its total debt.
Reducing Debt: KZR's debt to equity ratio has increased from 0% to 7.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: KZR has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: KZR has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 23.4% each year.